VIM and familial pancreatic carcinoma: For example, gemcitabine-resistant pancreatic cancer cells display increased vimentin expression (Traub et al, 1985), and vimentin expression increased in Panc-1 cell lines when treated by TGFbeta (Nakajima et al, 2004).